Orlando, FL -- (SBWIRE) -- 10/10/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Aastrom Biosciences Inc (NASDAQ:ASTM), Array Biopharma Inc (NASDAQ:ARRY).
Aastrom Biosciences Inc (NASDAQ:ASTM) shares declined 11.25% to $0.224. On September 24, 2013, Aastrom entered into a Warrant Exercise Agreement with two holders of warrants issued by the Company on August 16, 2013 to purchase an aggregate of 7,333,000 shares of the Company's common stock, no par value. Pursuant to the Warrant Exercise Agreements, the Holders agreed to exercise the 2013 Warrants at the existing exercise price of $0.375 in exchange for a fee of an aggregate amount of approximately $1,209,945. The net proceeds to the Company in connection with the exercise of the 2013 Warrants, after deducting estimated expenses, are approximately $1,470,000. As a result of these transactions, there are now 22,667,000 2013Warrants outstanding and the warrant liability has been reduced by approximately 24%.
Are investors worried about the recent updates with ASTM? Find out with a free trend analysis HERE
Array Biopharma Inc (NASDAQ:ARRY) shares dropped 8.12% to $5.32. The company announced that its Chief Executive Officer, Ron Squarer, spoke at the NewsMakers in the Biotech Industry Conference on Friday, September 27, 2013 at 10:30 a.m. Eastern Time
Additionally, Ratcliffe Liam who is Director at Array BioPharma, Inc. (NASDAQ:ARRY), sold 546,660 shares at $6.01 per share for a total value of $3,287,668 on Sept. 17.
Is ARRY going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)